Navigation Links
XYMOGEN Named Among The Nation's Fastest Growing Private Companies For The Sixth Time
Date:9/4/2013

ORLANDO, Fla., Sept. 4, 2013 /PRNewswire/ -- Orlando-based health-sciences company XYMOGEN announced today that it has been ranked for the sixth time to Inc. Magazine's Inc. 5000 list, which recognizes the fastest growing, most innovative, inspiring and best-run private companies in the nation. 

Inc. Magazine compiles the annual list based on revenue growth over a three-year period.  XYMOGEN is listed alongside such prominent brands as LivingSocial, Edible Arrangements and Zappos and is one of 33 Central Florida-based organizations to have made the 2013 lineup.  As a six-time honoree, XYMOGEN is part of an exclusive group known as the Honor Roll Alumni, a select circle of businesses to have made the list at least five times.

With 85 percent revenue growth and over 200 jobs added since 2012, XYMOGEN is one of few companies to thrive during a tough economic time.  The company attributes its continuous praises and accolades to a solid company culture and a team of passionate employees.

"This honor is truly a testament to the hard work and dedication of the XYMOGEN family," said CEO Brian Blackburn. "The company's continued growth and success is a reflection of the innovation and customer-focused mentality that our employees work toward every day."

XYMOGEN has over a quarter century of experience in providing quality professional supplements to healthcare practitioners.  The independent health sciences company has also introduced numerous innovations to the medical community. 

About XYMOGEN

XYMOGEN, a family-owned, health sciences company with headquarters in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century.

The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who represent a broad range of specialties. XYMOGEN's unprecedented growth continues with a strategic international expansion, which includes Canada and Australia, two of the largest international markets.

XYMOGEN's strength as a company was reinforced in 2007, 2008, 2010, 2011, 2012 and 2013 when it was recognized by Inc. Magazine as one of the 5,000 fastest-growing (best run, most innovative and most inspiring) private companies in America.

The company's 136,000-square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International.

More information is available at www.xymogen.com.

Please email pr@xymogen.com for comments or inquiries.

Distributed by Sara Brady Public Relations, Inc.
222 W. Comstock Avenue, Suite 215
Winter Park, Florida  32789
www.sarabradypr.com

For information, contact:
Kristin Colville 
407-702-6634

 


'/>"/>
SOURCE XYMOGEN
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
2. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
3. USANA Named One Of Americas Best Places To Work By Outside Magazine For 5th Consecutive Year
4. ChanTest CEO named Distinguished Service Award recipient by the Safety Pharmacology Society
5. Roger Graham Named President of Mylan Specialty
6. Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings
7. Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS
8. Baby Eva Named After Pioneering IVF Test
9. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
10. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
11. Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... Georgia Urology, ... Dr. Kristi Hebert to its newest location in East Cobb (4800 ... Dr. Hebert come aboard,” said Dr. Mark A. Haber, Georgia Urology’s managing partner. “She ...
(Date:8/17/2017)... Houston, Texas (PRWEB) , ... August 17, 2017 ... ... Dr. Rukmini “Vinaya” Rednam distinguishes herself once more by being among Houston’s first ... clientele receives the highest quality plastic surgery care without disrupting busy schedules and ...
(Date:8/17/2017)... ... ... SeQuel Response announced today that for the fourth consecutive year, ... companies in the U.S., putting it in the top 10 percent of applicants nationwide. ... Inc. 5000 over the years, only a fraction have made the list more ...
(Date:8/17/2017)... ... 2017 , ... CareAcademy, a provider of specialized online training ... in seed funding to further expand its course portfolio and increase its market ... the company’s primary investors. , Founded in 2016, CareAcademy currently serves ...
(Date:8/17/2017)... Ca (PRWEB) , ... August 17, 2017 , ... Centrifugation ... useful tools in the laboratory that we can no longer do without. And just ... the lifetime of your device. , In this webinar, attendees will learn about the ...
Breaking Medicine News(10 mins):